Twelve months after surgery, 39% of men in the NeuroSAFE arm had no or mild erectile dysfunction 3. In those men who had standard surgery this was 23%. A year after their operation, only 38% of those ...

Professor Greg Shaw, the trial lead from UCL Surgery & Interventional Science and Consultant Urologist at UCLH, said, "Our results show that, by using NeuroSAFE, nearly twice as many men don't have to ...

The NeuroSAFE technique significantly improves erectile function outcomes post-prostatectomy, nearly doubling the number of patients with no or mild erectile dysfunction. Intraoperative tissue ...

Twelve months after surgery, 39% of men in the NeuroSAFE arm had no or mild erectile dysfunction 3. In those men who had standard surgery this was 23%. A year after their operation, only 38% of those ...

A new surgical technique known as NeuroSAFE is offering new hope to men undergoing prostate cancer surgery, nearly doubling the chances of preserving erectile function without compromising cancer ...

Low-intensity extracorporeal shock wave therapy (LI-SWT) did not improve erectile dysfunction compared to a sham procedure in radical prostatectomy patients. Fewer than 20% of men in the LI-SWT group ...

After prostate cancer treatment, nearly all men suffer temporary or long-term erectile dysfunction. To keep the possibility of recovery alive, some active housekeeping is needed, in the form of penile ...

Localized prostate cancer treatments include radical prostatectomy and focal therapy, with the latter targeting only cancerous areas to preserve healthy tissue. Focal therapy allows for active ...